For Actavis, the new approval helps it extend its presence in the field – having bought Durata Therapeutics along with its recently approved antibiotic Dalvance (dalbavancin) in October. Avycaz ...

Second US Case of E coli Resistant to Last-Resort Antibiotic The New York case ... 2016 Alert FDA Approves Updated Label for Avycaz The FDA has approved a supplemental New Drug Application ...